BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9111279)

  • 1. Composition of peripheral blood progenitor cell components collected from healthy donors.
    Stroncek DF; Clay ME; Smith J; Herr G; Ilstrup S; Kunkel LA; McCullough J
    Transfusion; 1997 Apr; 37(4):411-7. PubMed ID: 9111279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.
    de Fabritiis P; Iori AP; Mengarelli A; Gozzer M; Ferrazza G; De Propris MS; Romano A; Arcese W
    Transfusion; 2001 Feb; 41(2):190-5. PubMed ID: 11239221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
    Engelhardt M; Bertz H; Wäsch R; Finke J
    Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection.
    Stroncek DF; Clay ME; Herr G; Smith J; Ilstrup S; McCullough J
    Transfusion; 1997 Mar; 37(3):304-8. PubMed ID: 9122904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
    Moncada V; Bolan C; Yau YY; Leitman SF
    Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
    Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
    Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
    Chaisiripoomkere W; Jootar S; Ungkanont A
    Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield.
    Yu J; Leisenring W; Bensinger WI; Holmberg LA; Rowley SD
    Transfusion; 1999 May; 39(5):442-50. PubMed ID: 10335991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
    Schwella N; Beyer J; Schwaner I; Heuft HG; Rick O; Huhn D; Serke S; Siegert W
    J Clin Oncol; 1996 Apr; 14(4):1114-21. PubMed ID: 8648365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
    Seong C; Durett A; Mirza N; Huh Y; Anderlini P; Champlin R
    Transfusion; 1997 Apr; 37(4):406-10. PubMed ID: 9111278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection of two peripheral blood stem cell concentrates from healthy donors.
    Stroncek DF; Clay ME; Jaszcz W; Lennon S; Smith J; McCullough J
    Transfus Med; 1999 Mar; 9(1):37-50. PubMed ID: 10216904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation.
    Snyder EL; Baril L; Cooper DL; Min K; Mechanic S; Stoddart L; Burtness B; Seagraves P; Debelak J; Gudino M; McCullough J
    Transfusion; 2000 Aug; 40(8):961-7. PubMed ID: 10960524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
    Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
    Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
    Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
    Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
    Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
    Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
    Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
    Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.